Who are Marker Therapeutics, Inc.'s main suppliers?

Marker Therapeutics, Inc. (MRKR) key suppliers include: CELL-READY-LLC. View the full supplier network at chainsifter.com/chain/MRKR.

Who are Marker Therapeutics, Inc.'s major customers?

Marker Therapeutics, Inc. (MRKR) key customers include: TScan Therapeutics, Inc.. View the full customer network at chainsifter.com/chain/MRKR.

What sector is Marker Therapeutics, Inc. in?

Marker Therapeutics, Inc. (MRKR) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

MRKR Supply Chain: Marker Therapeutics, Inc. Suppliers & Customers

1Suppliers

1Customers

2Debt Items

12Related Chains

Marker Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
CELL-READY-LLC	CELL-READY-LLC	90%	During the three months ended March 31, 2025, the Company incurred $ 0.6 million in expenses related to services and manufacturing costs and paid $ 2.6 million for invoices received.

Marker Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
TCRX	TScan Therapeutics, Inc.	72%	Reciprocal relationship from TCRX graph: ding transposase enzyme, which is derived from sfR fall armyworm, to deliver our TCRs into the genome of T cells. Our transposon/transposase system effectivel…

Marker Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
MRKR-DEBT-11067	Warrants outstanding: 716819	90%	xbrl warrant detail from xbrl 2020-12-31.
MRKR-DEBT-11068	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2016-12-31.

Marker Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Marker Therapeutics, Inc..

Marker Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
MRKR-OWNER-NEA-MANAGEMENT-COMPANY-LLC	NEA Management Company, LLC	90%	13F overlay lists NEA Management Company, LLC as top holder; 36 tracked holders.

Marker Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
MYGN	Myriad Genetics, Inc.	100.00	2
NVSEF	Novartis AG	100.00	2
ALLO	Allogene Therapeutics, Inc.	50.00	2
IPSC	Century Therapeutics, Inc.	50.00	2
AUTL	Autolus Therapeutics plc	50.00	2
IOVA	Iovance Biotherapeutics, Inc.	50.00	2
LYEL	Lyell Immunopharma, Inc.	50.00	2
LEGN	Legend Biotech Corporation	50.00	2
REGN	Regeneron Pharmaceuticals, Inc.	50.00	2
TCRX	TScan Therapeutics, Inc.	36.29	1	['customer']
AMGN	Amgen Inc.	24.13	2
AMGEN	AMGEN	24.13	2

Marker Therapeutics, Inc. Supply Chain